newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders

BOSTON, Oct. 7, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO) ("Stealth" or the "Company"), a clinical-stage biotechnology company focused on the discovery, development and